p53-Independent Activities of MDM2 and Their Relevance to Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 5, Iss. 1, 2005-02 ,pp. : 9-20

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Modeling Approaches in the Discovery of New Drugs for Anti-Cancer Therapy: The Investigation of p53-MDM2 Interaction and its Inhibition by Small Molecules

By  

Current Medicinal Chemistry, Vol. 17, Iss. 28, 2010-09 ,pp. : 3142-3154

Bentham Science Publishers

Access to resources Recommend Favorite

Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part I: targeting p53, Mdm2, GADD153/CHOP, GRP78/BiP and heat shock proteins

By Hiss Donavon C   Gabriels Gary A  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 8, 2009-08 ,pp. : 799-821

Informa Healthcare

Access to resources Recommend Favorite

Reactivation of p53 by Novel MDM2 Inhibitors: Implications for Pancreatic Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 10, Iss. 3, 2010-05 ,pp. : 319-331

Bentham Science Publishers

Access to resources Recommend Favorite

Patented small molecule inhibitors of p53–MDM2 interaction

By Deng Jinxia   Dayam Raveendra   Neamati Nouri  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 2, 2006-02 ,pp. : 165-188

Informa Healthcare

Access to resources Recommend Favorite